跳至主要内容
临床试验/NCT02879227
NCT02879227已完成2 期

Phase II of Radiochemotherapy in Elderly Patients With Oesophagus Cancer

Centre Hospitalier Universitaire de Besancon0 个研究点目标入组 23 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
23
主要终点
Feasibility of treatment: Number of patients with completed treatment

研究概览

简要总结

Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.

详细描述

Phase II study of radiochemotherapy for elderly patients with oesophagus cancer with Radiotherapy = 50 Gy, 2Gy/f ans chemotherapy with 2 arms arm Cisplatin = Cisplatin 75mg/m2 J1J22 or arm Oxaliplatine = oxaliplatine 85mg/m2 every 2 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
75 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients aged 75 or more with oesophagus cancer (squamous or adenocarcinoma), fit to treat

排除标准

  • previous radiotherapy
  • no fit to treat

研究组 & 干预措施

Arm Cisplatin

Active Comparator

Radiotherapy 50 Gy with cisplatin 75 mg/2 Day 1 and day 22 (2)

干预措施: Cisplatin (Drug)

Arm Oxaliplatin

Experimental

Radiotherapy 50Gy Oxaliplatin 85mg/m2 every 2 weeks, (6)

干预措施: Oxaliplatin (Drug)

结局指标

主要结局

Feasibility of treatment: Number of patients with completed treatment

时间窗: 6 weeks after end of the radiochemotherapy

number of patient with completed treatment

次要结局

  • Tumoral response(6 weeks after end of the radiochemotherapy)
  • Quality of life(6 weeks after end of the radiochemotherapy)

研究者

申办方类型
Other
责任方
Sponsor

相似试验